GlassScriptPhysician profile
Marlon A Lee
NPI 1861637522
$3,316.80
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $395 · 2021: $30.67 · 2022: $134 · 2023: $536 · 2024: $1,803 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,404 · Food and Beverage: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,404.04 |
| Food and Beverage | $1,134.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,774.61 | 2021-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Philips North America LLC | $589.10 | 2022-2023 | |
| Abbott Laboratories | $229.97 | 2024 | Esprit |
| Z-Medica, LLC | $202.66 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $148.48 | 2020-2023 | Crosser Iq |
| Medtronic Vascular, INC. | $127.58 | 2020 | |
| Silk Road Medical, INC. | $57.14 | 2020 | |
| Cook Medical LLC | $42.15 | 2019 | |
| Medtronic, INC. | $36.71 | 2025 | Hawkone |
| Venturemed Group, INC. | $24.40 | 2022 | |
| Covidien LP | $23.81 | 2019 | |
| Boston Scientific Corporation | $16.46 | 2019 | |
| Stryker Corporation | $15.85 | 2025 | Flowtriever |
| Cardiovascular Systems INC. | $14.90 | 2019 | |
| Getinge USA Sales, LLC | $12.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.